QNRX
Quoin Pharmaceuticals Ltd.
NASDAQ:QNRX
$12.9M MC · 588.2K shares · 3 employees

Quoin Pharmaceuticals Ltd. Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Content on this page require a membership to view — $9/mo.

News

This data requires membership
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
biotech.bet © 2026